ヘマスタチンの総合成
Kyan A D'Angelo1, Carly K Schissel1, Bradley L Pentelute1,2,3,4
1Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
まとめ
研究者は複雑なホモディメア構造を持つ自然産物であるヒマスタチンの完全な合成を達成しました. この画期的な発見により,新しいヒマスタチン誘導体と抗生物質の探査機が開発され,さらに研究が進められます.
科学分野:
- 自然製品化学
- 有機合成
- 薬剤化学
背景:
- ヒマスタチンは複雑なホモディメア構造を特徴とする天然産物である.
- ヒマスタチンの複雑な構造は,化学合成に重大な課題をもたらす.
研究 の 目的:
- ヒマスタチンの総合成を簡潔に記述する.
- ヒマスタチン誘導体を生成するためのモジュラー合成プラットフォームを作成します.
- ヒマスタチンの抗生物質活性を調べるためのプローブを合成する.
主な方法:
- バイオゲネシスに触発された最終段階の二分化戦略が採用された.
- 簡単に入手できる前駆物質が合成に使用された.
- モジュラー合成により,様々な派生物が作られました.
主要な成果:
- ヒマスタチンの簡潔な全合成が成功しました.
- ヒマスタチン の 設計 派生 剤 は 12 種類 以上 合成 さ れ まし た.
- 抗生物質の活性に関する洞察を提供する合成探査機が作られました.
結論:
- 開発された合成戦略は,ヒマスタチンとその類型に効率的なアクセスを提供します.
- この研究は,ヒマスタチンの生物学的機能と治療の可能性のさらなる調査を容易にする.
- 合成探知器は 抗生物質の作用の仕組みを理解するのに 価値のあるツールです
さらに関連する動画
11:44Synthesis and Structure Determination of µ-Conotoxin PIIIA Isomers with Different Disulfide Connectivities
Published on: October 2, 2018
12.7K
07:59A High-Yield Streptomyces Transcription-Translation Toolkit for Synthetic Biology and Natural Product Applications
Published on: September 10, 2021
4.3K
関連する概念動画
Hybridoma Technology
13.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.2K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
3.2K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
3.2K
EDTA: Auxiliary Complexing Reagents
1.6K
EDTA titrations are usually carried out in highly basic conditions, where the fully deprotonated form of EDTA, Y4−, actively complexes with the free metal ions in the solution. Several metal ions precipitate as hydrous oxide (hydroxides, oxides, or oxyhydroxides) under these conditions, lowering the concentration of free metal ions in the solution. For this reason, auxiliary complexing agents or ligands such as ammonia, tartrate, citrate, or triethanolamine are used in EDTA titrations to...
1.6K
Masking and Demasking Agents
4.1K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
4.1K
iChip
105
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...
105
Anthelminthic Agents
103
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
103
